|Long-term survival for patients with non–small-cell lung cancer with intratumoral lymphoid structures|
MC Dieu-Nosjean, M Antoine, C Danel, D Heudes, M Wislez, V Poulot, ...
Journal of Clinical Oncology 26 (27), 4410-4417, 2008
|Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives|
J Mazieres, S Peters, B Lepage, AB Cortot, F Barlesi, M Beau-Faller, ...
Journal of clinical oncology 31 (16), 1997-2003, 2013
|Primary pulmonary lymphoma|
J Cadranel, M Wislez, M Antoine
European Respiratory Journal 20 (3), 750-762, 2002
|Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer|
JS Lim, A Ibaseta, MM Fischer, B Cancilla, G O’Young, S Cristea, VC Luca, ...
Nature 545 (7654), 360-364, 2017
|Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network|
M Beau-Faller, N Prim, AM Ruppert, I Nanni-Metéllus, R Lacave, L Lacroix, ...
Annals of oncology 25 (1), 126-131, 2014
|Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death|
M Wislez, N Rabbe, J Marchal, B Milleron, B Crestani, C Mayaud, ...
Cancer research 63 (6), 1405-1412, 2003
|Nfib promotes metastasis through a widespread increase in chromatin accessibility|
SK Denny, D Yang, CH Chuang, JJ Brady, JS Lim, BM Grüner, SH Chiou, ...
Cell 166 (2), 328-342, 2016
|Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort|
J Mazieres, F Barlesi, T Filleron, B Besse, I Monnet, M Beau-Faller, ...
Annals of Oncology 27 (2), 281-286, 2016
|Clinical characteristics and prognostic factors of pulmonary MALT lymphoma|
R Borie, M Wislez, G Thabut, M Antoine, A Rabbat, LJ Couderc, I Monnet, ...
European Respiratory Journal 34 (6), 1408-1416, 2009
|TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung AdenocarcinomaTP53, STK11, and EGFR Mutations Predict Response to Anti–PD-1|
J Biton, A Mansuet-Lupo, N Pécuchet, M Alifano, H Ouakrim, J Arrondeau, ...
Clinical Cancer Research 24 (22), 5710-5723, 2018
|Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset|
I Tillie-Leblond, M Wislez, D Valeyre, B Crestani, A Rabbat, D Israel-Biet, ...
Thorax 63 (1), 53-59, 2008
|Acute Respiratory Failure Following HAART Introduction in Patients Treated for Pneumocystis carinii Pneumonia|
M WISLEZ, E BERGOT, M ANTOINE, A PARROT, MF CARETTE, ...
American journal of respiratory and critical care medicine 164 (5), 847-851, 2001
|Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras|
M Wislez, ML Spencer, JG Izzo, DM Juroske, K Balhara, DD Cody, ...
Cancer research 65 (8), 3226-3235, 2005
|High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras|
M Wislez, N Fujimoto, JG Izzo, AE Hanna, DD Cody, RR Langley, H Tang, ...
Cancer research 66 (8), 4198-4207, 2006
|Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma|
T Vieira, N Girard, M Ung, I Monnet, A Cazes, P Bonnette, M Duruisseaux, ...
Journal of Thoracic Oncology 8 (12), 1574-1577, 2013
|SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines|
J Zhang, S Kalyankrishna, M Wislez, N Thilaganathan, B Saigal, W Wei, ...
The American journal of pathology 170 (1), 366-376, 2007
|High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor|
N Fujimoto, M Wislez, J Zhang, K Iwanaga, J Dackor, AE Hanna, ...
Cancer research 65 (24), 11478-11485, 2005
|Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations|
M Wislez, J Cadranel, M Antoine, B Milleron, M Bazot, C Mayaud, ...
European Respiratory Journal 14 (2), 423-429, 1999
|Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature|
C Comarmond, B Crestani, A Tazi, B Hervier, S Adam-Marchand, ...
Medicine 93 (24), 2014
|Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis|
L Sesé, H Nunes, V Cottin, S Sanyal, M Didier, Z Carton, D Israel-Biet, ...
Thorax 73 (2), 145-150, 2018